Tumor Necrosis Factor Inhibitors May Slow the Progression of Spondyloarthritis
Therapeutic Drug Monitoring May Offer Little Benefit to Patient Remission Rates During Infliximab Induction Therapy
Case Report: A Non-Tuberculous Mycobacterial Infection
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR Convergence
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Meeting Abstracts
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.